Kestra Investment Management LLC Boosts Stock Position in Colgate-Palmolive (NYSE:CL)

Kestra Investment Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 57.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,379 shares of the company's stock after acquiring an additional 5,984 shares during the quarter. Kestra Investment Management LLC's holdings in Colgate-Palmolive were worth $1,489,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Chicago Partners Investment Group LLC lifted its position in Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock valued at $591,000 after buying an additional 943 shares during the period. Peak Financial Advisors LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at $1,315,000. Gordian Advisors LLC purchased a new position in Colgate-Palmolive during the third quarter valued at $602,000. Carrera Capital Advisors lifted its position in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock valued at $4,066,000 after buying an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at $4,066,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded up $1.69 during trading hours on Friday, reaching $89.56. 4,747,229 shares of the stock traded hands, compared to its average volume of 4,884,892. The company has a 50 day moving average price of $88.94 and a 200 day moving average price of $95.91. The firm has a market capitalization of $72.68 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a one year low of $84.45 and a one year high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Analysts Set New Price Targets

Several equities analysts have commented on CL shares. Piper Sandler lowered their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. Finally, Raymond James restated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.